Citrate and hydroxycinnamate derivatives from Mume Fructus could relieve LPS-induced intestinal epithelial cell injury by regulating the FAK/PI3K/AKT signaling pathway and thus should be considered as potential therapeutic targets for CD (Liu et al., 2023). Here, PTK2 is linked to Cowden disease.